Bar Plot from Scientific Research

A threshold-based analysis revealed that a ≥5% improvement in cUHDRS was achieved in approximately twice as many participants receiving pridopidine compared with placebo at weeks 26 ( P = 0.004) and 39 ( P = 0.003). All statistical tests were two-sided and unadjusted for multiple comparisons. Error bars represent 95% CI. ** P < 0.01.

DOI